Program Overview

---

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises.

Admission Criteria

• ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.
• The course is prioritized for ST-läkare with the shortest time left to specialist competence.

Application and Registration

• Registration is binding, and cancellation later than six weeks before the course start will result in a fee of 50% of the course cost.
• Cancellation later than four weeks before the course start will result in the full course cost being charged.

Additional Information

• The course is organized by the Hudkvast group and Karolinska Institutet.
• The course language is Swedish.
• The course includes a course dinner on Thursday evening. NA

Program Overview

The Karolinska Institutet offers a range of educational programs and courses, including a course on melanocytic tumors for ST-läkare (specialist doctors in clinical pathology).

Course Details

• Course Name: Kurs i melanocytära tumörer för ST-läkare, v6 2026
• Duration: 2-6 February 2026
• Location: Karolinska Universitetslaboratoriet, Solna
• Course Fee: 7,800 SEK
• Maximum Number of Participants: 30

Course Objectives

The course aims to provide fundamental knowledge in the assessment of melanocytic tumors according to the latest WHO classification.

Target Audience

The target audience is ST-läkare in clinical pathology with at least two years of experience and preferably experience in the diagnosis of melanocytic tumors.

Course Content

• Melanocyte biology, benign melanocytic tumors, "special site" lesions
• Intermediate melanocytic lesions - including grading of dysplastic nevi and borderline between melanoma in situ
• Introduction to MpathDx 2.0 categorization
• Melanoma and sentinel node biopsy
• Spitz tumors
• "Blue, BAP1, WNT" tumors and combination tumors
• Practical melanoma diagnosis with dermatoscopy
• Integration of molecular analyzes / NGS
• Quiz

Literature

• WHO classification, Chapter on melanocytic tumors, 2023, beta version, 5th ed.: Classification of Skin Tumors
• Other literature, such as:
  • Hudkvast document: National care program melanoma: Categorization of the tumor
  • Histopathological assessment and grading of dysplastic nevus: For the diagnosis of dysplastic nevus, requirements
  • Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques, Yeh I. Sem in diagnostic Pathol 2022; 39: 248-256.

Course Schedule

• The course starts with two days of self-study (Monday and Tuesday) and then three days on-site (Wednesday to Friday).
• The course includes lectures, case discussions, and practical exercises